Asiamah Rebecca, Mukkamalla Shiva Kumar, Sahai Tanmay, Zhou Xiao Ping, Han Eric, Armenio Vincent
Internal Medicine, Roger Williams Medical Center.
Internal Medicine/Hematology and Oncology, Roger Williams Medical Center.
Cureus. 2017 May 10;9(5):e1238. doi: 10.7759/cureus.1238.
Multiple myelomas is a neoplastic plasma cell disorder that accounts for one percent of all cancers and 13% of hematologic malignancies. Although primarily known to be a bone marrow disorder, it can metastasize to extramedullary sites or it can present as a solitary extramedullary plasmacytoma. Primary pleural effusion from myeloma is rare, occurring in less than one percent of the patients. The following case report highlights a case of bilateral pleural effusion, directly attributable to multiple myeloma after other causes were ruled out. The diagnosis was made using cytology and immunohistochemical (IHC) staining of the pleural fluid. Myelomatous pleural effusion (MPE) is a poor prognostic feature heralding an aggressive underlying disease state, as represented in this case.
多发性骨髓瘤是一种肿瘤性浆细胞疾病,占所有癌症的1%,血液系统恶性肿瘤的13%。虽然主要被认为是一种骨髓疾病,但它可转移至髓外部位,或表现为孤立性髓外浆细胞瘤。骨髓瘤引起的原发性胸腔积液很少见,发生率不到1%。以下病例报告重点介绍了一例双侧胸腔积液病例,在排除其他病因后,直接归因于多发性骨髓瘤。诊断通过胸腔积液的细胞学和免疫组织化学(IHC)染色做出。骨髓瘤性胸腔积液(MPE)是一种预后不良的特征,预示着潜在的侵袭性疾病状态,本病例即如此。